Skip to main content
. 2019 Jul 15;11(7):4508–4515.

Figure 3.

Figure 3

Anti-tumor effect of PRO-007 in FGFR2-modified GC cell lines. A. The viability of NCI-N87 cells transfected with FGFR2 cDNA was measured by the CTG assay after treatment with PRO-007 at 30 μg/ml. FGFR2 expression was confirmed by an immunoblotting assay. B. The viability of KATOIII cells transfected with FGFR2 shRNA was measured by the CTG assay after treatment with PRO-007 at 30 μg/ml. An immunoblotting assay showed decreased FGFR2 expression after transfection with FGFR2 shRNA.